The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.

作者信息

Jirasiritham S, Sumethkul V, Mavichak V, Chalermsanyakorn P

机构信息

Departments of Surgery, Medicine, and Pathology, Ramathibodi Hospital Medical School, Mahidol University, Bangkok, Thailand.

出版信息

Transplant Proc. 2000 Nov;32(7):2040-2. doi: 10.1016/s0041-1345(00)01549-9.

DOI:10.1016/s0041-1345(00)01549-9

PMID:11120057

Abstract

摘要

相似文献

The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.

Transplant Proc. 2000 Nov;32(7):2040-2. doi: 10.1016/s0041-1345(00)01549-9.

Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group.

Transplant Proc. 1997 Feb-Mar;29(1-2):348-9. doi: 10.1016/s0041-1345(96)00302-8.

Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience.

Transplant Proc. 1998 Nov;30(7):3576-7. doi: 10.1016/s0041-1345(98)01142-7.

Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.

Transplant Proc. 1999 Feb-Mar;31(1-2):1131-2. doi: 10.1016/s0041-1345(98)01933-2.

Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study.

Transplant Proc. 1999 Sep;31(6):2267-9. doi: 10.1016/s0041-1345(99)00332-2.

Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.

Transplant Proc. 1998 Jun;30(4):1562-3. doi: 10.1016/s0041-1345(98)00358-3.

Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.

Transplant Proc. 1997 Dec;29(8):3669-70. doi: 10.1016/s0041-1345(97)01067-1.

Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function.

Transplant Proc. 1998 Aug;30(5):2229. doi: 10.1016/s0041-1345(98)00600-9.

Mycophenolate mofetil decreases the risk for chronic renal allograft failure.

Transplant Proc. 2001 Feb-Mar;33(1-2):1005-6. doi: 10.1016/s0041-1345(00)02305-8.

Mofetil mycophenolate in renal transplantation.

Transplant Proc. 2001 Feb-Mar;33(1-2):1082-3. doi: 10.1016/s0041-1345(00)02425-8.

引用本文的文献

Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.

Cochrane Database Syst Rev. 2015 Dec 3;2015(12):CD007746. doi: 10.1002/14651858.CD007746.pub2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.

Transplant Proc. 2000 Nov;32(7):2040-2. doi: 10.1016/s0041-1345(00)01549-9.

Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group.

Transplant Proc. 1997 Feb-Mar;29(1-2):348-9. doi: 10.1016/s0041-1345(96)00302-8.

Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience.

Transplant Proc. 1998 Nov;30(7):3576-7. doi: 10.1016/s0041-1345(98)01142-7.

Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.

Transplant Proc. 1999 Feb-Mar;31(1-2):1131-2. doi: 10.1016/s0041-1345(98)01933-2.

Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study.

Transplant Proc. 1999 Sep;31(6):2267-9. doi: 10.1016/s0041-1345(99)00332-2.

Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.

Transplant Proc. 1998 Jun;30(4):1562-3. doi: 10.1016/s0041-1345(98)00358-3.

Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.

Transplant Proc. 1997 Dec;29(8):3669-70. doi: 10.1016/s0041-1345(97)01067-1.

Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function.

Transplant Proc. 1998 Aug;30(5):2229. doi: 10.1016/s0041-1345(98)00600-9.

Mycophenolate mofetil decreases the risk for chronic renal allograft failure.

Transplant Proc. 2001 Feb-Mar;33(1-2):1005-6. doi: 10.1016/s0041-1345(00)02305-8.

Mofetil mycophenolate in renal transplantation.

Transplant Proc. 2001 Feb-Mar;33(1-2):1082-3. doi: 10.1016/s0041-1345(00)02425-8.

引用本文的文献

Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.

Cochrane Database Syst Rev. 2015 Dec 3;2015(12):CD007746. doi: 10.1002/14651858.CD007746.pub2.